October 31, 2016
Finnish patent office accepts Faron’s new formulation for a respiratory orphan disease ARDS
Finish patent office has accepts Faron’s new formulation for a respiratory orphan disease ARDS
Pharmaceuticals, Biotechnology and Life Sciences
Finish patent office has accepts Faron’s new formulation for a respiratory orphan disease ARDS
Faron Pharmaceuticals (Faron), the clinical stage biopharmaceutical company, has recruited the first patient in the Japanese Phase III pivotal clinical trial for the…